FDG PET/CT in monitoring treatment of retroperitoneal fibrosis

Date
2012
Author
Asa, S.
Sonmezoglu, K.
Halac, M.
Tan, Y. Z.
Ozhan, M.
Yilmaz, S.
Metadata
Show full item record
Abstract
Retroperitoneal fibrosis is an uncommon disease characterized by inflammatory fibrosis typically surrounding abdominal aorta and iliac arteries. The glucose analogue F18-fluorodeoxyglucose can be used to image inflammatory cell activity non-invasively by PET. In this report we investigated the usefulness of the FDG PET/CT in the disease activity and therapy response evaluation of retroperitoneal fibrosis. (C) 2012 Elsevier Espana, S.L. and SEMNIM. All rights reserved.
URI
http://hdl.handle.net/20.500.12627/165996
https://doi.org/10.1016/j.remn.2012.04.001
Collections